AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) has received approval from ...

The FDA has approved Enhertu (fam-trastuzumab deruxtecan-nxki) for HR-positive, HER2-low or HER2-ultralow metastatic breast cancer.

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, ...

San Francisco, US Friday, January 17, 2025, 09:00 Hrs [IST] ...

The regenerating cellular elements, believed to be alveolar lining cells, were usually related ... bronchioles in bronchopulmonary dysplasia stain more readily with basic dyes than the usual ...

The authors examine the role of Numb, a Notch inhibitor, in intestinal stem cell self-renewal in Drosophila during homeostasis and regeneration. This is an important study providing evidence of a Numb ...

This study presents a valuable finding on the alterations in the autophagic-lysosomal pathway in a Huntington's disease model. The evidence supporting the claims of the authors is solid. However, the ...

Total cell counts were determined using an automated cell counter ... coli ΔLpp and ClearColi OMVs were labeled with CellMask Deep Red plasma membrane stain (ThermoFisher, #C10046) through a 1 h ...

Annexin V-PE and 7-AAD staining solutions were then added to ... transferred onto a polyvinylidene difluoride (PVDF) membrane and incubated overnight with primary antibodies from Cell Signaling ...

We generated a new type of MHC multimers, which can be monomerized in the presence of a competitor, resulting in rapid loss of the staining reagent. Following dissociation, the T cells are ...